
Category: What is the status of cancer research?
What cancers are being studied, what we know about them, and what are the latest findings?



Nationwide study reveals the deadly impact of the coronavirus on cancer patients In a study of 2,000 cancer patients, hydroxychloroquine showed no clinical benefit. Remdesivir was associated with a lower mortality risk but only certain groups of patients had access to it. Cancer patients also showed a higher risk of dying within 30 days of receiving a coronavirus diagnosis.
August 6, 2020 by Jocelyn Solis-Moreira Read More



